Indeed, elevated SAA1 had been found to be associated with increased expression levels of the M2 macrophage marker CD163 and the monocyte marker CXCR4 in AGII‐IV/GBM patients (Knebel et al., 2017). Here, CD163 is linked to glioblastoma.